European Commission approves Astellas’ drug for expanded prostate cancer Treatment Astellas Pharma Inc. revealed that XTANDITM (enzalutamide) has received a label extension from the European Commission, marking it as the inaugural and only novel hormone therapy endorsed for ... 04/23/2024 - 10:50 pm | View Link
New Urine Test for Prostate Cancer May Help Reduce Unnecessary Biopsies A prostate cancer biomarker test that utilizes genes indicating high-grade prostate cancer appears highly accurate. 04/22/2024 - 12:19 am | View Link
New insight into combatting drug-resistant prostate cancer Due to these drug resistance and cancer-promoting effects, it is important to study how the glucocorticoid receptor functions ... 04/16/2024 - 7:41 pm | View Link
Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation Arvinas entered into a strategic license agreement with Novartis for the development and commercialization of ARV-766. Learn more about ARVN and NVS stock here. 04/11/2024 - 8:49 am | View Link
Bill Zielinski helped oversee the city’s response to a ransomware attack and a massive data loss involving police records, WFAA reports. The resignation is set to take effect April 30.
While the health care system in New Mexico often feels overburdened, some of the state’s top providers are doing their part to discover innovative solutions to alleviate hardships.
As Northrop Grumman marks its first anniversary at Max Q, Thunderbird Kirtland Development LLC, is now focusing on attracting prospective tenants to a 70-acre mixed-use development at Kirtland Air Force Base.